NORDH Stock Overview
Nordhealth AS provides cloud-based healthcare software-as-a-services (SaaS) in Nordic region and internationally.
Nordhealth AS Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||kr25.10|
|52 Week High||kr32.00|
|52 Week Low||kr15.20|
|1 Month Change||3.72%|
|3 Month Change||-7.04%|
|1 Year Change||25.50%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-32.16%|
Recent News & Updates
|NORDH||NO Healthcare Services||NO Market|
Return vs Industry: NORDH exceeded the Norwegian Healthcare Services industry which returned 1.6% over the past year.
Return vs Market: NORDH exceeded the Norwegian Market which returned 3.8% over the past year.
|NORDH Average Weekly Movement||10.3%|
|Healthcare Services Industry Average Movement||6.2%|
|Market Average Movement||5.0%|
|10% most volatile stocks in NO Market||10.8%|
|10% least volatile stocks in NO Market||2.6%|
Stable Share Price: NORDH is more volatile than 75% of Norwegian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: NORDH's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
Nordhealth AS provides cloud-based healthcare software-as-a-services (SaaS) in Nordic region and internationally. The company acquires, manages, and builds SaaS practice management software (PMS) for approximately 50,000 veterinary and therapy, such as physiotherapy, psychotherapy, occupational, and speech therapy professionals across 13,000 clinics and hospitals located in 30 countries. Its products include Provet Cloud, a PMS that helps users in saving time and focus on what matters most; Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists in Norway; Psykbase, a PMS for psychologists and psychotherapists in Norway; EasyPractice, a PMS for therapists in Denmark; and various practice management software for veterinarians, including Provet Net in Finland, Vetserve and Sanimalis in Norway, and Vetvision in Denmark, as well as Vetera in Germany, Austria, and Switzerland.
Nordhealth AS Fundamentals Summary
|NORDH fundamental statistics|
Is NORDH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NORDH income statement (TTM)|
|Cost of Revenue||€27.96m|
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 14, 2023
|Earnings per share (EPS)||-0.17|
|Net Profit Margin||-39.47%|
How did NORDH perform over the long term?See historical performance and comparison